| Beta_blockers_class_review_September_2025.docx |
Beta_blockers_class_review_September_2025.docx |
|
| Beta_Blockers_(cardioselective)_Scheduled_Class_Review_Supplement_October_2025.docx |
Beta_Blockers_(cardioselective)_Scheduled_Class_Review_Supplement_October_2025.docx |
|
| Beta_Blockers_(non-cardioselective)_Scheduled_Class_Review_October_2025.docx |
Beta_Blockers_(non-cardioselective)_Scheduled_Class_Review_October_2025.docx |
|
| Angiotensin-Converting_Enzyme_Inhibitors_(ACEIs)_Scheduled_Class_Review_Supplement_October_2025.docx |
Angiotensin-Converting_Enzyme_Inhibitors_(ACEIs)_Scheduled_Class_Review_Supplement_October_2025.docx |
|
| ARBs___ACE_inhibitors_class_review_scheduled_October_2025.docx |
ARBs___ACE_inhibitors_class_review_scheduled_October_2025.docx |
|
| Angiotensin_Receptor_Blockers_(ARBs)_Scheduled_Class_Review_Supplement_October_2025.docx |
Angiotensin_Receptor_Blockers_(ARBs)_Scheduled_Class_Review_Supplement_October_2025.docx |
|
| Diuretics_Class_Review_October_2025.docx |
Diuretics_Class_Review_October_2025.docx |
|
| Diuretics_Class_Review_Supplement_1_Potassium-sparing_diuretics___Osmotic_Diuretics_October_2025.docx |
Diuretics_Class_Review_Supplement_1_Potassium-sparing_diuretics___Osmotic_Diuretics_October_2025.docx |
|
| Diuretics_Class_Review_Supplement_2_Loop_Diuretics_October_2025.docx |
Diuretics_Class_Review_Supplement_2_Loop_Diuretics_October_2025.docx |
|
| Diuretics_Class_Review_Supplement_3_Carbonic_Anhydrase_Inhibitors___Thiazide_Diuretics_October_2025.docx |
Diuretics_Class_Review_Supplement_3_Carbonic_Anhydrase_Inhibitors___Thiazide_Diuretics_October_2025.docx |
|
| Diuretics_Class_Review_Supplement_4_Thiazide-like_Diuretics_October_2025.docx |
Diuretics_Class_Review_Supplement_4_Thiazide-like_Diuretics_October_2025.docx |
|
| Cholesterol_lowering_agents_class_review_October_2025.docx |
Cholesterol_lowering_agents_class_review_October_2025.docx |
|
| Cholesterol_lowering_agents_(Miscellaneous_lipid_lowering_agents)_class_review_October_2025.docx |
Cholesterol_lowering_agents_(Miscellaneous_lipid_lowering_agents)_class_review_October_2025.docx |
|
| Cholesterol_lowering_agents_(Bile_acid_sequestrants)_class_review_October_2025.docx |
Cholesterol_lowering_agents_(Bile_acid_sequestrants)_class_review_October_2025.docx |
|
| Cholesterol_lowering_agents_(Fibric_Acid_Derivatives)_class_review_October_2025.docx |
Cholesterol_lowering_agents_(Fibric_Acid_Derivatives)_class_review_October_2025.docx |
|
| Cholesterol_lowering_agents_(PCSK9_pathway_agents)_class_review_October_2025.docx |
Cholesterol_lowering_agents_(PCSK9_pathway_agents)_class_review_October_2025.docx |
|
| Cholesterol_lowering_agents_(Statins)_class_review_October_2025.docx |
Cholesterol_lowering_agents_(Statins)_class_review_October_2025.docx |
|
| Calcium_Channel_Blockers_Supplement_Dihydropyridines_October_2025.docx |
Calcium_Channel_Blockers_Supplement_Dihydropyridines_October_2025.docx |
|
| Calcium_Channel_Blockers_Supplement_Dihydropyridines_2_October_2025.docx |
Calcium_Channel_Blockers_Supplement_Dihydropyridines_2_October_2025.docx |
|
| Calcium_Channel_Blockers_Supplement_Diltiazem_October_2025.docx |
Calcium_Channel_Blockers_Supplement_Diltiazem_October_2025.docx |
|
| Calcium_Channel_Blockers_Supplement_Verapamil_October_2025.docx |
Calcium_Channel_Blockers_Supplement_Verapamil_October_2025.docx |
|
| Calcium_Channel_Blockers_Class_Review_October_2025.docx |
Calcium_Channel_Blockers_Class_Review_October_2025.docx |
|
| Ophthalmic_Prostaglandin_Analogs_Class_Review_October_2025.docx |
Ophthalmic_Prostaglandin_Analogs_Class_Review_October_2025.docx |
|
| Ophthalmic_Carbonic_Anhydrase_Inhibitors_October_2025.docx |
Ophthalmic_Carbonic_Anhydrase_Inhibitors_October_2025.docx |
|
| Ophthalmic_Beta-blockers_Class_Review_October_2025.docx |
Ophthalmic_Beta-blockers_Class_Review_October_2025.docx |
|
| Ophthalmic_Alpha-2_Agonists_Class_Review_October_2025.docx |
Ophthalmic_Alpha-2_Agonists_Class_Review_October_2025.docx |
|
| Ophthalmic_NSAIDs_Class_Review_October_2025.docx |
Ophthalmic_NSAIDs_Class_Review_October_2025.docx |
|
| Ophthalmic_Corticosteroids_Class_Review_October_2025.docx |
Ophthalmic_Corticosteroids_Class_Review_October_2025.docx |
|
| Ophthalmic_Fluoroquinolones_and_Macrolides_Class_Review_October_2025.docx |
Ophthalmic_Fluoroquinolones_and_Macrolides_Class_Review_October_2025.docx |
|
| Ophthalmic_Local_Anesthetics_Class_Review_October_2025.docx |
Ophthalmic_Local_Anesthetics_Class_Review_October_2025.docx |
|
| Ophthalmic_Miotics_Class_Review_October_2025.docx |
Ophthalmic_Miotics_Class_Review_October_2025.docx |
|
| Ophthalmic_Anticholinergics_(Mydriatics)_October_2025.docx |
Ophthalmic_Anticholinergics_(Mydriatics)_October_2025.docx |
|
| Ophthalmic_Vasoconstrictors_Class_Review_October_2025.docx |
Ophthalmic_Vasoconstrictors_Class_Review_October_2025.docx |
|
| Ophthalmics_October_2025.docx |
Ophthalmics_October_2025.docx |
|
| Alpha-Glucosidase_Inhibitors_Scheduled_Class_Review_October_2025.docx |
Alpha-Glucosidase_Inhibitors_Scheduled_Class_Review_October_2025.docx |
|
| Dipeptidyl_Peptidase-4_Inhibitors_Scheduled_Class_Review_Piedmont_October_2025.docx |
Dipeptidyl_Peptidase-4_Inhibitors_Scheduled_Class_Review_Piedmont_October_2025.docx |
|
| GLP-1_Agonists_Scheduled_Class_Review_October_2025.docx |
GLP-1_Agonists_Scheduled_Class_Review_October_2025.docx |
|
| GLP-1_Agonists_Scheduled_Class_Review_Supplement_October_2025.docx |
GLP-1_Agonists_Scheduled_Class_Review_Supplement_October_2025.docx |
|
| Meglitinides_Scheduled_Class_Review_October_2025.docx |
Meglitinides_Scheduled_Class_Review_October_2025.docx |
|
| SGLT-2_Inhibitors_Scheduled_Class_Review_October_2025.docx |
SGLT-2_Inhibitors_Scheduled_Class_Review_October_2025.docx |
|
| Sulfonylureas_Scheduled_Class_Review_October_2025.docx |
Sulfonylureas_Scheduled_Class_Review_October_2025.docx |
|
| Insulins_(Short-acting)_Scheduled_Class_Review_October_2025.docx |
Insulins_(Short-acting)_Scheduled_Class_Review_October_2025.docx |
|
| Insulins_(Rapid-acting)_Scheduled_Class_Review_October_2025.docx |
Insulins_(Rapid-acting)_Scheduled_Class_Review_October_2025.docx |
|
| Insulins_(Premixed_NPH)_Scheduled_Class_Review_October_2025.docx |
Insulins_(Premixed_NPH)_Scheduled_Class_Review_October_2025.docx |
|
| Insulins_(Intermediate-acting_NPH)_Scheduled_Class_Review_October_2025.docx |
Insulins_(Intermediate-acting_NPH)_Scheduled_Class_Review_October_2025.docx |
|
| Insulins_(Long-acting)_Scheduled_Class_Review_October_2025.docx |
Insulins_(Long-acting)_Scheduled_Class_Review_October_2025.docx |
|
| Anti-diabetes_Overview_Therapeutic_Interchanges_and_Costs_October_2025.docx |
Anti-diabetes_Overview_Therapeutic_Interchanges_and_Costs_October_2025.docx |
|
| Triptans_Class_Review_November_2025.docx |
Triptans_Class_Review_November_2025.docx |
|
| Triptans_Class_Review_Supplement_November_2025.docx |
Triptans_Class_Review_Supplement_November_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Literature_September_2025.docx |
Respiratory_Inhalers_Class_Review_Literature_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_1_LABA_ICSs___LABA_LAMA_ICSs_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_1_LABA_ICSs___LABA_LAMA_ICSs_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_2_SABAs_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_2_SABAs_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_3_SAMA___LAMAs_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_3_SAMA___LAMAs_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_4_SABA_SAMAs___LABA_LAMAs_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_4_SABA_SAMAs___LABA_LAMAs_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_5_LABAs_and_SABA_ICS_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_5_LABAs_and_SABA_ICS_September_2025.docx |
|
| Respiratory_Inhalers_Class_Review_Supplement_6_ICSs_September_2025.docx |
Respiratory_Inhalers_Class_Review_Supplement_6_ICSs_September_2025.docx |
|